CLINICAL_TRIALS
trial_result
· 2018-11-07
Clinical Trial Update: Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery [Phase 2]
Summary
Phase 2 trial evaluating individualized temozolomide in patients with unresectable Stage IV melanoma; trial completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Recurrent Melanoma, Stage IV Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2018-11-07